# Comparison of Naloxone Pharmacokinetics

> **NCT03386591** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 30 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Naloxone
- **DEVICE:** Mucosal atomization device and syringe
- **DEVICE:** Narcan
- **DEVICE:** Intramuscular Auto Injector

## Key facts

- **NCT ID:** NCT03386591
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-03
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-03-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03386591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03386591, "Comparison of Naloxone Pharmacokinetics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03386591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*